ArticleBiophotonics discovery2025
Identification of colorectal malignancies enabled by phasor-based autofluorescence lifetime macroimaging and ensemble learning.
Article in Biophotonics discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Colorectal cancer (CRC) remains one of the most frequent cancers and a leading contributor to cancer-associated mortality globally. CRCs are often diagnosed at an advanced stage, which leads to high mortality and morbidity. This outcome is exacerbated by high rates of recurrence and postoperative complications that contribute substantially to poor prognosis. Advancements in endoscopic assessment have improved CRC prevention, early detection, and surveillance over the years. Yet, CRC remains one of the most significant health challenges of the 21st century. Label-free optical spectroscopy methods have long been explored as potential partners to endoscopy, not only to enhance diagnostic accuracy but also to confer predictive capabilities to endoscopic evaluations. Aim: We investigated the potential of time-resolved autofluorescence measurements excited at 375 and 445 nm to correctly classify benign and malignant tissues in CRC surgical specimens from 117 patients. Approach: Multiparametric autofluorescence lifetime data were collected in two distinct datasets, which were used for training ( Results: Using 5-fold cross-validation, we achieved Conclusions: Although preliminary, our findings underscore the potential impact of AI-assisted autofluorescence lifetime measurements in advancing CRC prevention, early detection, and surveillance efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.